Q9UBL3 (ASH2L_HUMAN) Homo sapiens (Human)
Set1/Ash2 histone methyltransferase complex subunit ASH2 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
27 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Cryo-EM structure of MLL1 core complex bound to the nucleosome |
Heteromer P02281; P06897; P61964; P62799; P84233; Q03164; Q15291; Q9C005; | 2×SAH; 2×ZN; | ||||
| Assess | ||||||
| Complex between MLL1-WRAD and an H2B-ubiquitinated nucleosome |
Heteromer B4DIJ7; P02281; P06897; P0CG47; P61964; P62799; P84233; Q15291; Q9C005; | 1×SAH; 1×ZN; | ||||
| Assess | ||||||
| Cryo-EM structure of MLL1-NCP (H3K4M) complex, mode02 |
Heteromer P02281; P06897; P61964; P62799; P84233; Q03164; Q15291; | |||||
| Assess | ||||||
| Cryo-EM structure of MLL1 in complex with RbBP5, WDR5, SET1, and ASH2L bound to the nucleosome (Cla… |
Heteromer P02281; P06897; P61964; P62799; P84233; Q03164; Q15291; | |||||
| Assess | ||||||
| Cryo-EM structure of MLL1 in complex with RbBP5, WDR5, SET1, and ASH2L bound to the nucleosome (Cla… |
Heteromer P02281; P06897; P61964; P62799; P84233; Q03164; Q15291; | |||||
| Assess | ||||||
| Cryo-EM structure of MLL1 in complex with RbBP5, WDR5, SET1, and ASH2L bound to the nucleosome (Cla… |
Heteromer P02281; P06897; P61964; P62799; P84233; Q03164; Q15291; | |||||
| Assess | ||||||
| Crystal structure of human Ash2L (SPRY domain and SDI motif) in complex with full length DPY-30 |
Heteromer Q9C005; | |||||
| Assess | ||||||
| The crystal structure of MLL1 (N3861I/Q3867L) in complex with RbBP5 and Ash2L |
Heteromer Q03164; Q15291; | 1×SAH; 1×ZN; | ||||
| Assess | ||||||
| Crystal structure of Ash2L SPRY domain in complex with phosphorylated RbBP5 |
Heteromer Q15291; | |||||
| Assess | ||||||
| The crystal structure of MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L in complex with H3K4me0 peptide |
Heteromer Q03164; Q15291; Q6NXT2; | 1×SAH; 1×ZN; | ||||
| Assess | ||||||
| Crystal structure of Ash2L SPRY domain in complex with RbBP5 |
Heteromer Q15291; | 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of the MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L complex |
Heteromer Q03164; Q15291; | 1×SAH; 1×ZN; | ||||
| Assess | ||||||
| The crystal structure of MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L in complex with H3K4me1 peptide |
Heteromer Q03164; Q15291; Q6NXT2; | 1×SAH; 1×ZN; | ||||
| Assess | ||||||
| The crystal structure of MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L in complex with H3K4me2 peptide |
Heteromer Q03164; Q15291; Q6NXT2; | 1×SAH; 1×ZN; | ||||
| Assess | ||||||
| The crystal structure of MLL3-RBBP5-ASH2L in complex with H3K4me0 peptide |
Heteromer Q15291; Q6NXT2; Q8NEZ4; | 2×ZN; 2×SAH; | ||||
| Assess | ||||||
| Crystal structure of the MLL3-Ash2L-RbBP5 complex |
Heteromer Q15291; Q6NXT2; Q8NEZ4; | 2×ZN; 2×SAH; | ||||
| Assess | ||||||
| The crystal structure of MLL2 in complex with ASH2L and RBBP5 |
Heteromer Q15291; Q9UMN6; | 1×ZN; 1×SAH; | ||||
| Assess | ||||||
| Cryo-EM structure of human MLL3-ubNCP complex (4.0 angstrom) |
Heteromer P02281; P06897; P61964; P62799; P62979; P84233; Q15291; Q8NEZ4; | 1×ZN; | ||||
| Assess | ||||||
| Cryo-EM structure of human MLL1-NCP complex, binding mode2 |
Heteromer P02281; P06897; P61964; P62799; P84233; Q03164; Q15291; | 1×SAH; 1×ZN; | ||||
| Assess | ||||||
| Cryo-EM structure of human MLL1-ubNCP complex (3.2 angstrom) |
Heteromer P02281; P06897; P61964; P62799; P62979; P84233; Q03164; Q15291; | 1×SAH; 1×ZN; 1×LYS; 1×GLN; | ||||
| Assess | ||||||
| Cryo-EM structure of human MLL1-ubNCP complex (4.0 angstrom) |
Heteromer P02281; P06897; P61964; P62799; P62979; P84233; Q03164; Q15291; | 1×SAH; 1×ZN; | ||||
| Assess | ||||||
| Cryo-EM structure of human MLL1-NCP complex, binding mode1 |
Heteromer P02281; P06897; P61964; P62799; P84233; Q03164; Q15291; | 1×SAH; 1×ZN; 1×LYS; 1×GLN; | ||||
| Assess | ||||||
| Cryo-EM structure of MLL1-NCP (H3K4M) complex, mode01 |
Heteromer P02281; P06897; P61964; P62799; P84233; Q03164; Q15291; | |||||
| Assess | ||||||
| Crystal structure of DPY-30 dimerization/docking domain in complex with Ash2L Sdc1-DPY-30 Interacti… |
Heteromer Q9C005; | 4×SO4; | ||||
| Assess | ||||||
| Structure of the SPRY domain of human Ash2L | homo-2-mer | |||||
| Assess | ||||||
| Crystal Structure of the N-terminal region of Human Ash2L | monomer | 1×ZN; | ||||
| Assess | ||||||
| Crystal structure of Ash2L N-terminal domain | monomer | 1×ZN; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7ud5.1.M | monomer | 0.66 | 100.00 | |||
| Assess | ||||||
3 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 6e2h.1.C | monomer | 0.67 | 89.18 | ||
| Assess | ||||||
| Isoform 2 | 7ud5.1.M | monomer | 0.61 | 100.00 | ||
| Assess | ||||||
| Isoform 3 | 7ud5.1.M | monomer | 0.67 | 100.00 | ||
| Assess | ||||||